View Clinical Trial (Medical Research Study)

A Study for Adult Patients With Fibromyalgia - NCT00965081-38119(Clinical Trial 330534)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Memphis
State:  
TN
Zip Code: 38119
Conditions: Fibromyalgia, Primary - Fibromyalgia, Secondary
Purpose: The main purpose of this study is to determine if 30mg of duloxetine is effective in the treatment of fibromyalgia compared to placebo.
Study summary:
Criteria: Inclusion Criteria: - Meet study criteria for fibromyalgia diagnosis. Exclusion Criteria: - Have previously or are currently taking duloxetine. - Have been diagnosed with certain psychoses, bipolar or schizoaffective disorder - Have pain symptoms that are difficult to differentiate from fibromyalgia. - Have seizure disorder, uncontrolled narrow angle glaucoma, or acute liver injury (such as hepatitis)or severe cirrhosis. - Have had any primary Axis 1 diagnosis other than major depressive disorder or generalized anxiety disorder within the past year. - Are pregnant or breast-feeding - Have a current or previous diagnosis of rheumatoid, infectious or inflammatory arthritis or an autoimmune disease - Have a regional pain syndrome, failed back syndrome or chronic localized pan related to any past surgery - Have a serious unstable medical illness - Have a history of substance abuse or dependence within the past year
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: July 12, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.